Taste and Smell Impairment in Critically Ill COVID-19 Patients

Evaluating the smell and taste perceptions of patients hospitalized in the intensive care unit with suspicion of Coronavirus disease-19 diagnosis with a survey study

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Smell Disorder Anosmia COVID-19 Coronaviridae Infections Coronavirus Infection Coronavirus Infections Dysgeusia Infections Lung Diseases Nervous System Diseases Neurologic Manifestations Nidovirales Infections Olfaction Disorders Pathological Conditions, Signs and Symptoms Pneumonia Pneumonia, Viral RNA Virus Infections Respiratory Tract Diseases Respiratory Tract Infections Sensation Disorders Signs and Symptoms Taste Disorders Virus Diseases

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Sisli Etfal Research and Training Hospital

Istanbul, 34371, Turkey (Türkiye)

About this study

Patients who were treated in the intensive care unit of Şişli Hamidiye Etfal Training and Research Hospital with the diagnosis of Coronavirus disease-19 will be determined by scanning the hospital registry system. It was planned that patients discharged from the intensive care unit would be called by phone and their complaints about smell and taste disorders were evaluated with a questionnaire.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Adults between the ages of 18-80
Agree to participate in the study
Patients treated in the intensive care unit with the diagnosis of Coronavirus disease-19

Exclusion criteria

Pre-existing smell and taste impairment
The patients have no enough cooperation to answer the questionnaire
Having additional diseases such as dementia and Alzheimer

Treatment and study plan

Primary outcomes

taste and smell impairment

Time frame: up to 3 months

incidence of taste and smell impairment in critically ill subjects

Sponsors and collaborators

Lead sponsor

Pinar Ay Sayin

Other

Registry information

Important dates

Study start: 2020
Primary completion: 2020
Study completion: 2020
First posted: Aug 31, 2020
Registry last updated: Nov 10, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed